Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $200
Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ: ILMN ) with a Overweight and raises the price target from $170 to $200.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.